Rocket Pharmaceuticals, INC.
Doing business as Rocket Pharmaceuticals Ny
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
US patents1
SAM.gov UEIX5FHW8WU5FA7
CAGE code9XAM3
Incorporated inDE
- genetic testing
- gene therapy
- clinical trials
- Danon Disease
- PKP2-ACM
- BAG3-DCM
- diseases
- Arrhythmogenic Cardiomyopathy
- Dilated Cardiomyopathy
- Leukocyte Adhesion Deficiency-I
- Fanconi Anemia
Named on the company’s own website, read SEP 9, 2026
Open positions
Openings read from Rocket Pharmaceuticals, INC.’s own job board on iCIMS, last checked OCT 26, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Facilities Technician ICranbury, NJ · posted SEP 28, 2026
- Senior Manager, Quality Control OperationsCranbury, NJ · posted SEP 20, 2026
- Vice President, Access, Value Evidence & PricingCranbury, NJ · posted SEP 15, 2026
- Senior AccountantCranbury, NJ · posted SEP 15, 2026
- Director, Business Insights & AnalyticsUNAVAILABLE, UNAVAILABLE · posted AUG 27, 2026
- Manager, External AffairsCranbury, NJ · posted AUG 24, 2026
- Specialist, IT – GxP Technical SupportCranbury, NJ · posted AUG 11, 2026
- Senior Engineer, IT - GxP Infrastructure & SystemsCranbury, NJ · posted AUG 11, 2026
- Manager, IT - GxP Systems & ComplianceCranbury, NJ · posted AUG 11, 2026
- Director, Internal & Employee CommunicationsCranbury, NJ · posted JUL 24, 2026
Patents
1 US patent granted JUL 7, 2020.
Pharmaceuticals 1
- Gene therapy vectors for treatment of Danon diseaseUS 10,703,797 · granted JUL 7, 2020
Granted to Rocket Pharmaceuticals, Ltd. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Rocket Pharmaceuticals, INC. | New York | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


